Published: Sun, October 18, 2020
Medical | By

Go-ahead for Russian Federation vaccine trial in India

Go-ahead for Russian Federation vaccine trial in India

A Phase III trial involving 40,000 participants is now underway in Moscow, with 16,000 people having already received the first dose of the two-shot vaccine.

Russian Federation is reported to be conducting phase 3 trials of Sputnik V in several other countries including Belarus, Venezuela, and the United Arab Emirates (UAE). Phase 3 trial for the vaccine was also started in the UAE last week.

Instead of focusing on their own vaccine development process, Russian Federation started a campaign to discredit Oxford's COVID-19 vaccine. India is cooperating in vaccine development with five pharma companies, including AstraZeneca and Novavax.

Previously, Dr.Reddys Laboratories Ltd. and the Russian Direct Investment Fund (the official sponsor of the vaccine candidate) had joined into a partnership to conduct clinical trials of Sputnik V vaccine and its distribution in India.

If the vaccine doesn't work, then "this is giving people a false sense of security", said Sridhar Venkatapuram, a specialist in bioethics at King's College London's Global Health Institute. Vaccine candidates in clinical trials vary in type and include DNA plasmid vaccines, inactivated virus vaccines, adenovirus-vectored vaccines, RNA vaccines, protein subunit vaccines and virus-like particle vaccines. That trial was limited to people under age 60.

Serum Institute of India can produce 700-800 million vaccine dosages every year once things are streamlined, he added.

While speaking on the COVID Vaccination & Consumers Rights, Prof Bejon Kumar Misra, International Consumer Policy Expert, Founder, JAGOGRAHAK.COM, Editor, The Aware Consumer, said, "Definitely, the vaccines will be a vital component in finally addressing the COVID-19 pandemic".

Recently, while attending an online WHO question-and-answer session, Dr Soumya Swaminathan, Chief Scientist, World Health Organization, reiterated that the WHO's stance against allowing the virus to spread unchecked to reach herd immunity, emphasizing that the concept should be discussed only within the context of a vaccine. "We don't know exactly how much, but we're proceeding with planning so that we can get the vaccine out to the people who want it as quickly as we can once it becomes available", Van Deusen said.

"We need to increase production of the first and second vaccine", he said in comments broadcast on state TV.

For Texans living in more remote areas, the state may have to step in to help, possibly sending in teams to help provide the vaccine to those who choose to take it.

Like this: